Clever Culture Systems Limited · ASX:CC5

Clever Culture Systems — DGHM 2022

28 slides from Clever Culture Systems's conference presentation, Sep 7, 2022

  1. Slide 1: Comparison of APAS to manual plate reading of clinical urine cultures

    DGHM 2022| Berlin |07.09.2022 Dr. med. Tobias Kramer Comparison of the automated plate assement system (APAS) to manual plate reading of clinical urine cultures

  2. Slide 2: Disclosure statement

    T. Kramer| APAS Independence Disclosure statement ■ Nothing to disclose in regards to this topic LADR Ihr Labor vor Ort | DGHM www.LADR.de Berlin | 07.09.2022 2

  3. Slide 3: Introduction

    T. Kramer| APAS Independence Introduction ■ Urines are one of the most frequent samples in a clinical microbiology lab ■ Plated on two different media ■ Incubation for 48h ■ Interpretation according to MIQ 2 (2020) ■ Automatisation can potentially help to free resources in a lab. LADR Ihr Labor vor

  4. Slide 4: Introduction II

    T. Kramer| APAS Independence Introduction II APAS Independence ■ IVD/CE; FDA clearance ■ documentation of plates (digital pictures) ■ Colony count ■ Identification ■ Sorting of plate: ■ negative ■ To review ■ Positive (ggf. + E.coli) ■ Transmission of results to the LIS LADR Ihr Labor vor Ort | DGHM

  5. Slide 5: Introduction III

    T. Kramer| APAS Independence Introduction III Automatically images, interprets Neat stacks of and sorts plates Positives into those to be Reviewed Negatives Capacity: 240 plates per session LADR Ihr Labor vor Ort | DGHM www.LADR.de Berlin | 07.09.2022 5

  6. Slide 6: Objective

    T. Kramer| APAS Independence Objective ■ Is the APAS Independence able to : ■ Correctly identify growth/colony count/ colony morphology ■ Sort agar plates correctly LADR Ihr Labor vor Ort | DGHM www.LADR.de Berlin | 07.09.2022 6

  7. Slide 7: Material & Methods

    T. Kramer| APAS Independence Material & Methods ■ LADR Zentrallabor Dr. Kramer & Kollegen ■ Private physician run and owned laboratory ■ Primary and tertiary medical centers ■ Clinical Microbiology: ■ 7 clinical microbiologists & 4 biologists ■ Approx. 450-500 urine samples for culturing per day LAD

  8. Slide 8: Material & Methoden II

    T. Kramer| APAS Independence Material & Methoden II ■ Plating automated or manually ■ Media used: ■ UTI clear (Oxoid/Thermofisher) ■ CNA (Oxoid/Thermofisher) ■ 1st reading after 18h LADR Ihr Labor vor Ort | DGHM www.LADR.de Berlin | 07.09.2022 8

  9. Slide 9: Methods

    T. Kramer| APAS Independence Methods ■ Samples in total n=382 ■ Randomly selected samples (MSU) ■ collected on different days/weeks ■ Manually plated ■ Prospective blinded evaluation with standard of diagnostic (manual reading with technicians n=5) ■ 18h of incubation ■ Evaluation if automatisation

  10. Slide 10: Results urines

    T. Kramer| APAS Independence Results urines ■ Overall n=382 ■ Samples included n=378 ■ True positives n=231 ■ False positives n=51 ■ True negatives n=92 ■ False negative n= 4 Plate image APAS reconstructed image LADR Ihr Labor vor Ort | DGHM www.LADR.de Berlin | 07.09.2022 10

  11. Slide 11: Results urines

    T. Kramer| APAS Independence Results urines Statistic Statistic Value 95% CI Sensitivity 98.30% 97.02% 95.70% to 98.79% 93.96% to 99.53% Specificity 64.34% 68.53% 55.90% to 76.03% 60.24% to 72.16% Positive LikelihoodRatio Positive Likelihood Ratio 2.76 3.08 2.21 to 3.93 2.42 to 3.44 Negative Likelih

  12. Slide 12: Results urines

    T. Kramer| APAS Independence Results urines ■ False positives n=51 ■ Colony Count “overestimated”(n=46) ■ “False” Pathogen suspected (n=4) ■ No clear interpretation (n=1) ■ False negative n= 4 ■ E. faecalis 10 to the 5 ■ E. coli 10 to the 7 (n=2) ■ K. pneumoniae 10 to the 3 and E. faecalis 10 to the

  13. Slide 13: Conclusion

    T. Kramer| APAS Independence Conclusion ■ APAS independence successfully identified and sorted relevant urine samples ■ False negatives detected at reading after 48h ■ Adds persistance ■ Documentation ■ Removing negative and non-significant urine cultures = 51.9% reduction in manual review LADR Ihr

  14. Slide 14: Thank you for your attention!

    T. Kramer| APAS Independence Thank you for your attention! Dr. med. Tobias Kramer, MSc. (LSHTM) Facharzt für Mikrobiologie, Virologie und Infektionsepidemiolgie Hygiene und Umweltmedizin ABS Expert (DGI) LADR Zentrallabor Dr. Kramer & Kollegen [email protected] LADR Ihr Labor vor Ort | DGHM www.LADR.

  15. Slide 15: Diagnostik

    T. Kramer| APAS Independence Diagnostik Interpretation ■ Infektion oder Kontamination? Hooton TM et al. ; NEJM 2013 LADR Ihr Labor vor Ort | DGHM www.LADR.de Berlin | 07.09.2022 15

  16. Slide 16: Diagnostik

    T. Kramer| APAS Independence Diagnostik Interpretation Schubert S et al. ; MIQ 2 2020 LADR Ihr Labor vor Ort | DGHM www.LADR.de Berlin | 07.09.2022 16

  17. Slide 17: Diagnostik

    T. Kramer| APAS Independence Diagnostik Interpretation ■ Interpretation des Befundes setzt Kenntnis von Leukozyturie voraus: ■ Beurteilung nur unter Berücksichtigung der Klinik und Leukozyturie möglich. ■ Bei Wachstum von 1-2 Spezies werden alle uropathogenen Erreger ab 1000 (10^3) KBE/ml differenzi

  18. Slide 18: Diagnostik

    T. Kramer| APAS Independence Diagnostik Interpretation Wachstum: ja KBE/ml KBE/ml 1-2 Spezies Bei besonderer klinischer Konstellation ≥10^3 ≥ 10^2 Typischer uropathogener ID + AB ID + AB u.a. Blasenpunktion Erreger (rot) Potentiell uropathogener ID + AB ID + AB Erreger (gelb) Kontaminante, kein ID I

  19. Slide 19: Einführung

    T. Kramer| APAS Independence Einführung ■ Fähigkeiten des Geräts ■ Ergebnisse Testläufe Geesthacht ■ VRE ■ MRSA ■ Urine ■ Probleme ■ Kosten ■ Fazit LADR Ihr Labor vor Ort | DGHM www.LADR.de Berlin | 07.09.2022 19

  20. Slide 20: Übersicht

    T. Kramer| APAS Independence Übersicht ■ Fähigkeiten des Geräts ■ Ergebnisse Testläufe Geesthacht ■ VRE ■ MRSA ■ Urine ■ Probleme ■ Kosten ■ Fazit LADR Ihr Labor vor Ort | DGHM www.LADR.de Berlin | 07.09.2022 20

  21. Slide 21: Ergebnisse

    T. Kramer| APAS Independence Ergebnisse ■ VRE ■ MRSA ■ Urine LADR Ihr Labor vor Ort | DGHM www.LADR.de Berlin | 07.09.2022 21

  22. Slide 22: Ergebnisse VRE

    T. Kramer| APAS Independence Ergebnisse VRE ■ Overall Samples n=102 Statistic Value 95% CI Sensitivity 100.00% 63.06% to 100.00% ■ True positives n=8 Specificity 94.95% 88.61% to 98.34% ■ False positives n=5 Positive Likelihood 19.80 8.43 to 46.52 Ratio ■ True negatives n=94 Negative Likelihood 0.00

  23. Slide 23: Ergebnisse MRSA

    T. Kramer| APAS Independence Ergebnisse MRSA ■ Overall Samples n= 714 Statistic Value 95% CI ■ True positives n= 18 Sensitivity 100.00% 81.47% to 100.00% ■ False positives n= 24 Specificity 96.55% 94.91% to 97.78% Positive Likelihood Ratio 29.00 19.57 to 42.97 ■ True negatives n= 676 Negative Likeli

  24. Slide 24: Kosten

    T. Kramer| APAS Independence Kosten LADR Ihr Labor vor Ort | DGHM www.LADR.de Berlin | 07.09.2022 24

  25. Slide 25: Proposal: Instrument + Software License

    T. Kramer| APAS Independence Proposal: Instrument + Software License Total investment €335,000 a discount of €160,000 over 5 years Instrument: €210,000 Discount = 23% / € 60,000 + List price is €270,000. The quoted price will be maintained for any further instruments purchased by the LADR group with

  26. Slide 26: Proposal

    T. Kramer| APAS Independence Proposal • LADR network instrument pricing – instrument list price € 270,000 special price of € 210,000 • Normal software licence € 15,000 p.a. per application per instrument – special pricing of three analysis modules €25,000 p.a. • LADR proposal software licence as a s

  27. Slide 27: Kosten

    T. Kramer| APAS Independence Kosten ■ Alternativer Bezug über Beckman Coulter (ggf.+ Autoplak) ■ Konditionen für mehrere Standorte (z.B. Neuruppin; Cave Anpassung Platensatz) LADR Ihr Labor vor Ort | DGHM www.LADR.de Berlin | 07.09.2022 27

  28. Slide 28: Fazit

    T. Kramer| APAS Independence Fazit ■ Fazit LADR Ihr Labor vor Ort | DGHM www.LADR.de Berlin | 07.09.2022 28

Clever Culture Systems — DGHM 2022 on 6ix